TABLE 1.

Percentage of Facilities Offering Intramuscular and Subcutaneous Injectables and With the Commodity in Stock Among Pilot and Non-Pilot Regions, PMA2020 Survey Rounds 3 and 4

Round 3Round 4
March–May 2016November 2016–January 2017
All RegionsIn the 4 Pilot RegionsIn the 9 Non-Pilot RegionsAll RegionsIn the 4 Pilot RegionsIn the 9 Non-Pilot Regions
All facilities
    Number of facilities13262701316170
    Offer IM-injectables, %84.183.984.391.690.292.9
    Offer IM-injectables and the method is in stock, %83.383.982.990.888.592.9
    Offer SC-injectables, %42.469.418.676.378.774.3
    Offer SC-injectables and the method is in stock, %39.464.517.167.977.060.0
Public facilities
    Number of facilities11051591165363
    Offer IM-injectables, %98.2100.096.6100.0100.0100.0
    Offer IM-injectables and the method is in stock, %97.3100.094.9100.0100.0100.0
    Offer SC-injectables, %50.084.320.385.390.681.0
    Offer SC-injectables and the method is in stock, %46.478.418.675.988.765.1
  • Abbreviations: IM, intramuscular; PMA2020, Performance Monitoring and Accountability 2020; SC, subcutaneous.